|
End-of-day quote
Shenzhen S.E.
12/08/2026
|
5-day change | 1st Jan Change | ||
| 37.11 CNY | +0.08% |
|
+2.46% | +10.61% |
| 07-27 | ApicHope Pharmaceutical Signs Clinical Trial Contract with Boji Medical Technology for Obesity Drug; Shares Rise 4% | MT |
| 07-24 | Declaration of Voting Results by ApicHope Pharmaceutical | CI |
| Market Cap | 16.64B 2.47B 2.14B 2B 1.83B 3.44B 235B 3.49B 23.57B 9.21B 118B 9.27B 9.07B 393B | P/E 2026 * |
32x | P/E 2027 * | -161x |
|---|---|---|---|---|---|
| Enterprise Value | 16.64B 2.47B 2.14B 2B 1.83B 3.44B 235B 3.49B 23.57B 9.21B 118B 9.27B 9.07B 393B | EV / Sales 2026 * |
15.4x | EV / Sales 2027 * | 13.2x |
| Free-Float |
31.84% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +0.08% | ||
| 1 week | +2.46% | ||
| Current month | +5.13% | ||
| 1 month | -6.64% | ||
| 3 months | -11.60% | ||
| 6 months | +10.45% | ||
| Current year | +10.61% |
| 1 week | 35.83 | 39.26 | |
| 1 month | 33.41 | 43.5 | |
| Current year | 29.31 | 45.88 | |
| 1 year | 29.31 | 76.88 | |
| 3 years | 12.74 | 81.48 | |
| 5 years | 12.74 | 81.48 | |
| 10 years | 7.58 | 81.48 |
| Manager | Title | Age | Since |
|---|---|---|---|
Han Xiong Li
CEO | Chief Executive Officer | 52 | 10/11/2015 |
Hui Xing Zhang
DFI | Director of Finance/CFO | 60 | 10/11/2015 |
Xiao Dong Liu
IRC | Investor Relations Contact | 38 | 30/12/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Han Xiong Li
CHM | Chairman | 52 | 10/11/2015 |
Han Dong Li
BRD | Director/Board Member | 58 | 10/11/2015 |
Liang Wen Huang
CHM | Chairman | 50 | 10/11/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 05/01/26 | Buy | Director | 4,200 | 0.0010% | ||
| 24/11/25 | Buy | Director | 7,000 | 0.0017% | ||
| 01/09/23 | Buy | 20,000 | 0.0089% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.08% | +2.46% | -43.95% | +82.99% | 2.47B | ||
| -0.30% | -0.67% | +18.18% | +70.85% | 48.9B | ||
| +1.31% | +1.93% | +55.04% | +124.00% | 40.42B | ||
| -2.68% | +5.82% | +18.60% | +82.73% | 12.6B | ||
| -0.29% | -1.27% | -6.58% | +18.02% | 12.39B | ||
| -0.19% | -0.76% | +30.40% | +135.91% | 9.07B | ||
| -0.08% | +7.60% | +24.69% | +40.11% | 7.53B | ||
| +0.29% | +3.61% | +39.38% | -12.72% | 7.13B | ||
| +0.29% | +1.00% | +12.98% | +187.43% | 6.78B | ||
| -0.87% | +2.74% | -25.38% | +28.51% | 5.83B | ||
| Average | -0.27% | +3.44% | +12.34% | +75.78% | 15.31B | |
| Weighted average by Cap. | -0.04% | +3.43% | +25.08% | +83.78% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.08B 160M 139M 130M 119M 223M 15.27B 226M 1.53B 598M 7.65B 601M 588M 25.5B | 1.26B 187M 162M 151M 138M 260M 17.79B 264M 1.78B 696M 8.91B 700M 685M 29.71B |
| Net income | 526M 78M 67.58M 63.32M 57.75M 109M 7.44B 110M 745M 291M 3.73B 293M 286M 12.42B | -102M -15.13M -13.1M -12.28M -11.2M -21.05M -1.44B -21.38M -144M -56.45M -722M -56.79M -55.55M -2.41B |
| Net Debt | - | - |
Employees
1,294
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/08/26 | CN¥37.11 | +0.08% | 10,038,222 |
| 11/08/26 | CN¥37.08 | -0.59% | 11,306,644 |
| 10/08/26 | CN¥37.30 | -1.82% | 15,164,694 |
| 07/08/26 | CN¥37.99 | +4.20% | 16,250,319 |
| 06/08/26 | CN¥36.46 | +0.66% | 12,081,814 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 300723 Stock
Select your edition
All financial news and data tailored to specific country editions
















